Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
235 East 42 Street, New York, NY, 10017, US
How Pfizer CentreOne helps customers navigate complexity in OSD manufacturing through a consistent network and targeted technical expertise at the site level.
Released By Pfizer CentreOne
The decision is based on the Phase 3 Breakwater trial, which showed improvements in progression‑free and overall survival.
By: Charlie Sternberg
Submission aims to expand HYMPAVZI indication to the treatment of hemophilia A or B patients 6 years and older with inhibitors, and pediatric patients without inhibitors.
Revenue in the quarter was down 1%, reports loss of $1.6 billion.
By: Kristin Brooks
Dr. David Townson offers a proven track record of advancing transformative oncology and cell therapy programs.
Aim to further develop, manufacture and commercialize YP05002 for weight management worldwide.
Revenue in the quarter was impacted by declines in COVID-19 product sales.
Acquisition would provide Pfizer entry into the lucrative weight-loss drug market.
Agrees to most-favored-nation pricing and plans further investment in U.S. R&D.
The agreement includes a 3-year tariff exemption for Pfizer products, contingent on increased U.S. manufacturing investment.
The proposed acquisition will add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline.
Insight on market dynamics driving OSD forms, key development and manufacturing challenges, and the specialized capabilities needed to address them.
The approval covers the LP.8.1-adapted vaccine, designed to address evolving SARS-CoV-2 sublineages.
CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.
Gains exclusive rights for the development, manufacturing and commercialization of 3SBio’s SSGJ-707.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
